No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
HAE Haemonetics
- 75.440
- -1.460-1.90%
Close Dec 20 16:00 ET
- 75.440
- 0.0000.00%
Post 16:15 ET
3.79BMarket Cap31.30P/E (TTM)
77.790High74.700Low1.50MVolume76.260Open76.900Pre Close113.73MTurnover3.02%Turnover Ratio32.94P/E (Static)50.22MShares97.97052wk High4.31P/B3.75BFloat Cap70.25052wk Low--Dividend TTM49.72MShs Float142.110Historical High--Div YieldTTM4.02%Amplitude6.344Historical Low75.675Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Haemonetics: Strong Market Position and Attractive Investment Opportunity Amid Growth in Plasma and Hospital Segments
Investors Three-year Returns in Haemonetics (NYSE:HAE) Have Not Grown Faster Than the Company's Underlying Earnings Growth
Should You Continue to Hold TMO Stock in Your Portfolio?
Are Investors Undervaluing Haemonetics (HAE) Right Now?
This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Analysts Offer Insights on Healthcare Companies: Haemonetics (HAE) and Terns Pharmaceuticals (TERN)
Heat List
US
Overall
Symbol
Price
% Chg
No Data